If you’ve been waiting for a serious postdoctoral breakthrough in biomedical and pharmaceutical research, this is the kind of opportunity that doesn’t stay open for long. The São Paulo Research Foundation (FAPESP) has officially opened applications for a prestigious Post-Doctoral Fellowship based at one of Latin America’s most respected medical research environments — the Heart Institute (InCor) at the University of São Paulo’s Hospital das Clínicas.
This is more than a lab position. It’s a high-impact, internationally open fellowship supporting cutting-edge cancer-related drug formulation research involving lipid nanoparticles and advanced pharmacological testing. With a generous monthly stipend and additional research funding, this fellowship is designed for ambitious early-career PhD holders ready to step into world-class scientific innovation.
What This Fellowship Offers (Stipend + Research Support)?
Winning this FAPESP Post-Doctoral Fellowship means entering Brazil’s leading scientific ecosystem with strong financial backing and full research immersion. The selected fellow will receive a monthly scholarship of BRL 12,570, allowing researchers to focus fully on discovery, experimentation, and publication without financial strain.
In addition to the stipend, FAPESP provides a research contingency fund worth 10% of the annual fellowship total, helping cover essential project-related expenses. This is a rare combination of personal funding and lab support, making the fellowship one of the most attractive postdoctoral opportunities currently open in pharmacology and biomedical sciences.
Research Focus: Lipid Nanoparticles + Cisplatin Innovation
This fellowship is tied to a major thematic research project supported by FAPESP and hosted at InCor, one of Brazil’s top clinical research institutes. The project aims to develop a lipophilic cisplatin derivative formulation delivered through lipid nanoparticles (LDE).
The work includes advanced studies such as:
- Stability and cytotoxicity testing
- Pharmacodynamic and pharmacokinetic evaluation
- Toxicological trials in mice and cell culture
- Proteomic research analysis
For postdoctoral researchers looking to work at the intersection of chemistry, pharmacology, oncology, and nanomedicine, this is an exceptional scientific platform.
Eligibility Requirements (Who Can Apply?)
To qualify, applicants must meet a few clear academic and research-based conditions. This fellowship is open globally and welcomes international candidates from all nationalities.
Eligible applicants include:
- Researchers holding a PhD earned no more than 7 years ago
- Candidates with doctoral training in:
- Chemistry
- Pharmacy
- Biology
- Biomedicine
- Related life-science disciplines
- Applicants of any nationality (fully international opportunity)
- Researchers interested in pharmacological sciences, nanomedicine, and translational biomedical studies.
The last date to apply for the FAPESP Post-Doctoral Fellowship in Chemistry / Pharmacology / Biology at the Heart Institute (InCor), University of São Paulo, is 13 February 2026 (23:59 UTC).